DNA 진단 시장 규모는 향후 수년간 급성장할 것으로 예상되며, 2029년에는 CAGR 10.8%로 386억 4,000만 달러에 달할 것으로 예상됩니다. 예측 기간의 성장은 암 유병률 증가, 표준화된 진단 검사에 대한 수요 증가, 유전성 질환의 유병률 증가, 바이오마커 탐색, 희귀질환, 희귀질환 치료제에 대한 관심 증가, 원격의료 및 원격 검사의 성장에 기인합니다. 예측 기간의 주요 동향으로는 마이크로바이옴 분석의 통합, 블록체인 기술 통합, 다중 오믹스 데이터 통합, 비침습적 검사, 멀티오믹스 통합, 휴대용 및 POC(Point-Of-Care) DNA 진단 기기 개발, 차세대 염기서열 분석기(NGS) 등이 있습니다.
유전성 질환의 발병률 증가는 당분간 DNA 진단 시장의 성장을 촉진할 것으로 보입니다. 유전체 이상으로 인한 건강 문제를 특징으로 하는 유전성 질환은 진단 능력의 향상, 다양한 유전자 검사의 가용성, 환경적 영향, 집단내 혈연 관계 등 여러 요인에 의해 증가 추세에 있습니다. 이러한 요인들은 전체적으로 유전성 질환에 대한 인식과 식별에 기여하고 있으며, DNA 진단약은 유전 물질 분석을 통해 유전성 질환을 정확하게 식별하고 조기 진단, 맞춤형 치료 접근법, 정보에 입각한 가족 계획 결정을 촉진하는 데 중요한 역할을 하고 있습니다. 예를 들어 2023년 2월 세계보건기구(WHO)에 따르면 선천성 질환은 전 세계에서 연간 약 24만 명의 신생아 사망의 원인이 되고 있으며, 생후 1개월에서 5세까지의 소아 사망자 중 17만 명이 선천성 질환으로 인해 사망하고 있습니다. 이에 따라 유전성 질환의 유병률이 증가하고 있으며, 이는 DNA 진단약 시장의 성장 촉진요인으로 작용하고 있습니다.
DNA 진단약 분야의 주요 기업은 다양한 유형의 암을 조기에 발견할 수 있도록 설계된 액체생검 검사와 같은 혁신적인 제품 개발에 힘쓰고 있습니다. 액체생검 검사는 혈류에 존재하는 순환종양세포(CTC), 무세포 DNA(cfDNA), 엑소좀(exosome) 등 종양이나 다른 세포에서 유래한 바이오마커를 확인 및 분석하는 저침습적 진단 접근법입니다. 예를 들어 2023년 5월 미국의 유명한 헬스케어 진단 회사인 Laboratory Corporation은 LabCorp Plasma Focus라는 새로운 액체생검 검사를 발표했습니다. 이 검사는 진행성 또는 전이성 고형 종양으로 진단받은 환자의 표적 치료법을 식별하기 위해 고안된 검사로, 유전자 시퀀싱 기술을 활용하여 종양 세포에서 방출되는 순환 유리 DNA(cfDNA)를 평가합니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나바이러스 및 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 DNA 진단약 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 용도 산업의 분석
- 세계의 DNA 진단약 시장 : 성장률 분석
- 세계의 DNA 진단약 시장 실적 : 규모와 성장, 2019-2024
- 세계의 DNA 진단약 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 DNA 진단약 TAM(Total Addressable Market)
제6장 시장 세분화
- 세계의 DNA 진단약 시장 : 제품 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 기기
- 시약
- 소프트웨어와 서비스
- 세계의 DNA 진단약 시장 : 기술별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 중합효소 연쇄 반응
- 마이크로어레이
- In Situ 하이브리다이제이션
- 시퀀싱 기술
- 질량분석
- 세계의 DNA 진단약 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 종양학
- 감염증 치료
- 근원성 질환의 치료
- 임상 진단 확인
- 출생전
- 착상전
- 기타 용도
- 세계의 DNA 진단약 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- POC(Point of Care)
- 진단 센터
- 자가 검사 또는 일반의약품(OTC)
- 세계의 DNA 진단약 시장, 기기의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- DNA 애널라이저
- PCR 머신(중합효소 연쇄 반응)
- 시퀸서(차세대 시퀀싱, 생어 시퀀싱)
- 전기영동 시스템
- 유전자 발현 애널라이저
- 마이크로어레이 시스템
- 유세포분석기
- 분광 광도계
- 세계의 DNA 진단약 시장, 시약의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- PCR 시약
- DNA 추출 키트
- 시퀀싱 시약
- DNA 탐지 용항체
- 형광 색소와 프로브
- 핵산 정제용 화학제품
- DNA 분석용 완충액
- 하이브리다이제이션 및 증폭 키트
- 세계의 DNA 진단약 시장, 소프트웨어의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- DNA 데이터 분석 소프트웨어
- 바이오인포매틱스 플랫폼
- 시퀀스 데이터용 유전체학 소프트웨어
- 검사 정보 관리 시스템(LIMS)
- 데이터 시각화 툴
- 유전자 변이 해석 소프트웨어
- 게놈 매핑 소프트웨어
- 세계의 DNA 진단약 시장, 서비스의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 유전자 검사 서비스
- DNA 시퀀싱 서비스
- 바이오인포매틱스 컨설팅 및 분석
- 임상 진단 서비스
- 유전 카운셀링 서비스
- 커스텀 DNA 진단약 서비스
- 연구개발 서비스
제7장 지역별·국가별 분석
- 세계의 DNA 진단약 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 DNA 진단약 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- DNA 진단약 시장 : 경쟁 구도
- DNA 진단약 시장 : 기업 개요
- F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
- Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
- Becton, Dickinson and Company
- Laboratory Corporation
- Quest Diagnostics Incorporated
- Eurofins Scientific SE
- Agilent Technologies
- Illumina Inc
- PerkinElmer Inc
- bioMerieux SA
- Beckman Coulter Inc
- Sysmex Corporation
- Bio-Rad Laboratories Inc
- QIAGEN N.V.
- Natera Inc
- Myriad Genetics Inc.
- BGI Genomics Co. Ltd.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- DNA 진단약 시장 2029 : 새로운 기회를 제공하는 국가
- DNA 진단약 시장 2029 : 새로운 기회를 제공하는 부문
- DNA 진단약 시장 2029 : 성장 전략
제36장 부록
KSA
DNA diagnostics involves utilizing genetic testing techniques to examine DNA, RNA, and proteins for medical, forensic, or research purposes. These tests offer valuable insights into genetic predispositions, disease susceptibility, and ancestry, thereby revolutionizing the fields of medicine and genetics and providing effective tools for health management.
DNA diagnostic products encompass instruments, reagents, software, and services. Instruments are specialized equipment used for DNA sample analysis, employing technologies such as polymerase chain reaction, microarray, in-situ hybridization, sequencing, and mass spectrometry. These technologies find applications in diverse areas including oncology, infectious disease treatment, myogenic disorder treatment, clinical diagnostics, prenatal and pre-implantation testing. End users of DNA diagnostic products include point-of-care facilities, diagnostic centers, and individuals seeking self-testing or over-the-counter solutions.
The DNA diagnostics market research report is one of a series of new reports from The Business Research Company that provides DNA diagnostics market statistics, including DNA diagnostics industry global market size, regional shares, competitors with a DNA diagnostics market share, detailed DNA diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the DNA diagnostics industry. This DNA diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The DNA diagnostics market size has grown rapidly in recent years. It will grow from $23.1 billion in 2024 to $25.67 billion in 2025 at a compound annual growth rate (CAGR) of 11.1%. The growth in the historic period can be attributed to rising demand for personalized medicine, increasing adoption of genetic testing and molecular diagnostics in clinical practice, rising biomedical research, the increasing number of cancer patients, and the growing use of diagnostics tests.
The DNA diagnostics market size is expected to see rapid growth in the next few years. It will grow to $38.64 billion in 2029 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to increasing the prevalence of cancers, increasing demand for standardized diagnostic tests, rising prevalence of genetic disorders, increasing focus on biomarker discovery, rare diseases and orphan drugs, and growth of telemedicine and remote testing. Major trends in the forecast period include the integration of microbiome analysis, integration of blockchain technology, the integration of multiple omics data, non-invasive testing, multi-omics integration, the development of portable and point-of-care DNA diagnostic devices, and next-generation sequencing (NGS).
The increasing incidence of genetic disorders is poised to drive the expansion of the DNA diagnostics market in the foreseeable future. Genetic disorders, characterized by health issues stemming from abnormalities in the genome, are on the rise due to several factors including enhanced diagnostic capabilities, broader genetic testing availability, environmental influences, and consanguinity within populations. These factors collectively contribute to a heightened awareness and identification of genetic disorders. DNA diagnostics plays a crucial role in precisely identifying genetic disorders through the analysis of genetic material, facilitating early diagnosis, tailored treatment approaches, and informed family planning decisions. For example, according to the World Health Organization (WHO) in February 2023, congenital diseases are responsible for approximately 240,000 neonatal deaths worldwide annually, with an additional 170,000 deaths occurring in children aged between 1 month and 5 years. Consequently, the escalating prevalence of genetic disorders serves as a key driver for the growth of the DNA diagnostics market.
Leading players in the DNA diagnostics sector are directing their efforts towards the development of innovative products, including liquid biopsy tests, designed to detect various types of cancer in their early stages. Liquid biopsy tests represent a minimally invasive diagnostic approach that identifies and analyzes biomarkers, such as circulating tumor cells (CTCs), cell-free DNA (cfDNA), or exosomes, present in the bloodstream and originating from tumors or other cells. For instance, in May 2023, Laboratory Corporation, a prominent US-based healthcare diagnostics company, introduced a novel liquid biopsy test named LabCorp Plasma Focus. This test is designed to identify targeted therapies for patients diagnosed with advanced or metastatic solid tumors. Leveraging genetic sequencing technology, LabCorp Plasma Focus evaluates circulating cell-free DNA (cfDNA) released by tumor cells, enabling oncologists to personalize treatment strategies and enhance patient care through targeted therapy plans.
In November 2022, Myriad Genetics Inc., a leading US-based company specializing in genetic testing and personalized medicine, acquired Gateway Genomics for approximately $67.5 million. This acquisition broadens Myriad's portfolio in women's health and oncology testing, offering patients more comprehensive and personalized genetic testing solutions. Gateway Genomics LLC, the acquired company, specializes in developing prenatal and pediatric genomic tests, aligning with Myriad's commitment to expanding its presence and capabilities in key segments of genetic diagnostics.
Major companies operating in the DNA diagnostics market are F. Hoffmann-La Roche Ltd, Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, Laboratory Corporation, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies, Illumina Inc, PerkinElmer Inc, bioMerieux SA, Beckman Coulter Inc, Sysmex Corporation, Bio-Rad Laboratories Inc, QIAGEN N.V., Natera Inc, Myriad Genetics Inc., BGI Genomics Co. Ltd., Cepheid, NeoGenomics Laboratories Inc, 23andMe Holding Co, Ambry Genetics Corporation, Biocartis SA, CENTOGENE N.V., Veritas Genetics
North America was the largest region in the DNA diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the DNA diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the DNA diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The DNA diagnostics market consists of revenues earned by entities by providing services such as ancestry testing, paternity or maternity testing, genetic health risk assessment, carrier testing, pharmacogenetic testing, forensic DNA analysis, and genetic counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The DNA diagnostics market also includes sales of DNA extraction kits, thermal cyclers or polymerase chain reaction machines, DNA sequencers, gel electrophoresis systems, DNA microarrays, automated liquid handling systems, and DNA storage and preservation kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
DNA Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on dna diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for dna diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dna diagnostics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Product Type: Instruments; Reagents; Software And Services
- 2) By Technology: Polymerase Chain Reaction; Microarray; In-situ Hybridization; Sequencing Technology; Mass Spectrometry
- 3) By Application: Oncology; Infectious Diseases Treatment; Myogenic Disorder Treatment; Clinical Diagnostic Confirmation; Prenatal; Pre-Implantation; Other Applications
- 4) By End User: Point Of Care; Diagnostic Centers; Self-Testing Or Over-The-Counter (OTC)
Subsegments
- 1) By Instruments: DNA Analyzers; PCR Machines (Polymerase Chain Reaction); Sequencers (Next-Generation Sequencing, Sanger Sequencing); Electrophoresis Systems; Gene Expression Analyzers; Microarray Systems; Flow Cytometers; Spectrophotometers
- 2) By Reagents: PCR Reagents; DNA Extraction Kits; Sequencing Reagents; Antibodies For DNADetection; Fluorescent Dyes And Probes; Chemicals For Nucleic Acid Purification; Buffer Solutions For DNA Analysis; Hybridization And Amplification Kits
- 3) By Software: DNA Data Analysis Software; Bioinformatics Platforms; Genomics Software For Sequencing Data; Laboratory Information Management Systems (LIMS); Data Visualization Tools; Genetic Variant Analysis Software; Genome Mapping Software
- 4) By Services: Genetic Testing Services; DNA Sequencing Services; Bioinformatics Consulting And Analysis; Clinical Diagnostic Services; Genetic Counseling Services; Custom DNA Diagnostics Services; Research And Development Services
- Companies Mentioned: F. Hoffmann-La Roche Ltd; Bayer AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. DNA Diagnostics Market Characteristics
3. DNA Diagnostics Market Trends And Strategies
4. DNA Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global DNA Diagnostics Growth Analysis And Strategic Analysis Framework
- 5.1. Global DNA Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global DNA Diagnostics Market Growth Rate Analysis
- 5.4. Global DNA Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global DNA Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global DNA Diagnostics Total Addressable Market (TAM)
6. DNA Diagnostics Market Segmentation
- 6.1. Global DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Instruments
- Reagents
- Software And Services
- 6.2. Global DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Polymerase Chain Reaction
- Microarray
- In-situ Hybridization
- Sequencing Technology
- Mass Spectrometry
- 6.3. Global DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oncology
- Infectious Diseases Treatment
- Myogenic Disorder Treatment
- Clinical Diagnostic Confirmation
- Prenatal
- Pre-Implantation
- Other Applications
- 6.4. Global DNA Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Point Of Care
- Diagnostic Centers
- Self-Testing Or Over-The-Counter (OTC)
- 6.5. Global DNA Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- DNA Analyzers
- PCR Machines (Polymerase Chain Reaction)
- Sequencers (Next-Generation Sequencing, Sanger Sequencing)
- Electrophoresis Systems
- Gene Expression Analyzers
- Microarray Systems
- Flow Cytometers
- Spectrophotometers
- 6.6. Global DNA Diagnostics Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- PCR Reagents
- DNA Extraction Kits
- Sequencing Reagents
- Antibodies For DNA Detection
- Fluorescent Dyes And Probes
- Chemicals For Nucleic Acid Purification
- Buffer Solutions For DNA Analysis
- Hybridization And Amplification Kits
- 6.7. Global DNA Diagnostics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- DNA Data Analysis Software
- Bioinformatics Platforms
- Genomics Software For Sequencing Data
- Laboratory Information Management Systems (LIMS)
- Data Visualization Tools
- Genetic Variant Analysis Software
- Genome Mapping Software
- 6.8. Global DNA Diagnostics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Genetic Testing Services
- DNA Sequencing Services
- Bioinformatics Consulting And Analysis
- Clinical Diagnostic Services
- Genetic Counseling Services
- Custom DNA Diagnostics Services
- Research And Development Services
7. DNA Diagnostics Market Regional And Country Analysis
- 7.1. Global DNA Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global DNA Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific DNA Diagnostics Market
- 8.1. Asia-Pacific DNA Diagnostics Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China DNA Diagnostics Market
- 9.1. China DNA Diagnostics Market Overview
- 9.2. China DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India DNA Diagnostics Market
- 10.1. India DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan DNA Diagnostics Market
- 11.1. Japan DNA Diagnostics Market Overview
- 11.2. Japan DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia DNA Diagnostics Market
- 12.1. Australia DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia DNA Diagnostics Market
- 13.1. Indonesia DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea DNA Diagnostics Market
- 14.1. South Korea DNA Diagnostics Market Overview
- 14.2. South Korea DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe DNA Diagnostics Market
- 15.1. Western Europe DNA Diagnostics Market Overview
- 15.2. Western Europe DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK DNA Diagnostics Market
- 16.1. UK DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany DNA Diagnostics Market
- 17.1. Germany DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France DNA Diagnostics Market
- 18.1. France DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy DNA Diagnostics Market
- 19.1. Italy DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain DNA Diagnostics Market
- 20.1. Spain DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe DNA Diagnostics Market
- 21.1. Eastern Europe DNA Diagnostics Market Overview
- 21.2. Eastern Europe DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia DNA Diagnostics Market
- 22.1. Russia DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America DNA Diagnostics Market
- 23.1. North America DNA Diagnostics Market Overview
- 23.2. North America DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA DNA Diagnostics Market
- 24.1. USA DNA Diagnostics Market Overview
- 24.2. USA DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada DNA Diagnostics Market
- 25.1. Canada DNA Diagnostics Market Overview
- 25.2. Canada DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America DNA Diagnostics Market
- 26.1. South America DNA Diagnostics Market Overview
- 26.2. South America DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil DNA Diagnostics Market
- 27.1. Brazil DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East DNA Diagnostics Market
- 28.1. Middle East DNA Diagnostics Market Overview
- 28.2. Middle East DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa DNA Diagnostics Market
- 29.1. Africa DNA Diagnostics Market Overview
- 29.2. Africa DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. DNA Diagnostics Market Competitive Landscape And Company Profiles
- 30.1. DNA Diagnostics Market Competitive Landscape
- 30.2. DNA Diagnostics Market Company Profiles
- 30.2.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
31. DNA Diagnostics Market Other Major And Innovative Companies
- 31.1. Becton, Dickinson and Company
- 31.2. Laboratory Corporation
- 31.3. Quest Diagnostics Incorporated
- 31.4. Eurofins Scientific SE
- 31.5. Agilent Technologies
- 31.6. Illumina Inc
- 31.7. PerkinElmer Inc
- 31.8. bioMerieux SA
- 31.9. Beckman Coulter Inc
- 31.10. Sysmex Corporation
- 31.11. Bio-Rad Laboratories Inc
- 31.12. QIAGEN N.V.
- 31.13. Natera Inc
- 31.14. Myriad Genetics Inc.
- 31.15. BGI Genomics Co. Ltd.
32. Global DNA Diagnostics Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The DNA Diagnostics Market
34. Recent Developments In The DNA Diagnostics Market
35. DNA Diagnostics Market High Potential Countries, Segments and Strategies
- 35.1 DNA Diagnostics Market In 2029 - Countries Offering Most New Opportunities
- 35.2 DNA Diagnostics Market In 2029 - Segments Offering Most New Opportunities
- 35.3 DNA Diagnostics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
